Mohammed M Milhem (Mohammed Milhem)

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 9

Top Topics

Herpes Simplex Virus

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

European journal of cancer care

This page only lists publications with an associated author ORCID identifier.

Publications

Lisa A Kottschade, Gregory Russell Pond, Anthony J Olszanski, Yousef Zakharia, Evidio Domingo-Musibay, Ralph J Hauke, Brendan D Curti, Sarah Schober, Mohammed M Milhem, Matthew S Block, Tina J Hieken, Robert R McWilliams
SALVO: Single Arm Trial of Ipilimumab and Nivolumab as Adjuvant Therapy for Resected Mucosal Melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Espen Basmo Ellingsen, Steven J O'Day, Artur Mezheyeuski, Agnieszka Gromadka, Trevor Clancy, Timothy S Kristedja, Mohammed M Milhem, Yousef Zakharia
Clinical Activity of Combined Telomerase Vaccination and Pembrolizumab in Advanced Melanoma: Results from a Phase I Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Merve Hasanov, Denái R Milton, William H Sharfman, Bret Taback, Lee D Cranmer, Gregory A Daniels, Lawrence Flaherty, Sigrun Hallmeyer, Mohammed M Milhem, Lynn G Feun, Ralph J Hauke, Gary Doolittle, Nancy Gregory, Sapna Pradyuman Patel
An Open-Label, Randomized, Multi-Center Study Comparing the Sequence of High Dose Aldesleukin (Interleukin-2) and Ipilimumab (Yervoy) in Patients with Metastatic Melanoma. Oncoimmunology 10 (1) (2021)
Kristin Baird, John Glod, Seth M Steinberg, Denise K Reinke, Joseph G Pressey, Leo Mascarenhas, Noah C Federman, Neyssa Marina, Sant Chawla, Joanne P Lagmay, John Goldberg, Mohammed M Milhem, David M Loeb, James E Butrynski, Brian Turpin, Arthur Staddon, Sheri L Spunt, Robin L Jones, Eve T Rodler, Scott M Schuetze, Scott H Okuno, Lee Helman
Results of a Randomized, Double-Blinded, Placebo-Controlled, Phase 2.5 Study of Saracatinib (AZD0530), in Patients with Recurrent Osteosarcoma Localized to the Lung. Sarcoma 2020 (2020)
Brigitte C Widemann, Yao Lu, Denise Reinke, Scott H Okuno, Christian F Meyer, Gregory M Cote, Rashmi Chugh, Mohammed M Milhem, Angela C Hirbe, Ae Rang Kim, Brian Turpin, Joseph G Pressey, Eva Dombi, Nalini Jayaprakash, Lee J Helman, Ndidi Onwudiwe, Karen Cichowski, John P Perentesis
Targeting Sporadic and Neurofibromatosis Type 1 (NF1) Related Refractory Malignant Peripheral Nerve Sheath Tumors (MPNST) in a Phase II Study of Everolimus in Combination with Bevacizumab (SARC016). Sarcoma 2019 (2019)
Umang Swami, Varun Monga, Aaron D Bossler, Yousef Zakharia, Mohammed M Milhem
Durable Clinical Benefit in Patients with Advanced Cutaneous Melanoma after Discontinuation of Anti-PD-1 Therapies Due to Immune-Related Adverse Events. Journal of oncology 2019 (2019)
Umang Swami, Brian Swick, Yousef Zakharia, Mohammed M Milhem
Clinical Challenges with Talimogene Laherparepvec: Cured Lymph Nodes Masquerading as Active Melanoma. Case reports in oncological medicine 2019 (2019)
Varun V Monga, Seth M Maliske, Hassan Kaleem, Sarah L Mott, Gideon K D Zamba, Mohammed M Milhem
Discrepancy between treatment goals documentation by oncologists and their understanding among cancer patients under active treatment with chemotherapy. European journal of cancer care 28 (2) (2018)
Karen A Malkhasyan, Yousef Zakharia, Mohammed M Milhem
Quality-of-life outcomes in patients with advanced melanoma: A review of the literature. Pigment cell & melanoma research 30 (6) (2017)